These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1171984)

  • 21. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
    Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo activation of synthetic hormonogens of lysine vasopressin: Na-glycyl-glycyl-glycyl-[8-lysine]vassopressin in the cat.
    Pliska V; Chard T; Rudinger J; Forsling ML
    Acta Endocrinol (Copenh); 1976 Mar; 81(3):474-81. PubMed ID: 946340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new series of photoactivatable and iodinatable linear vasopressin antagonists.
    Carnazzi E; Aumelas A; Barberis C; Guillon G; Seyer R
    J Med Chem; 1994 Jun; 37(12):1841-9. PubMed ID: 8021923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [1-Deaminopenicillamine,4-threonine]oxytocin, a potent inhibitor of oxytocin.
    Manning M; Lowbridge J; Seto J; Haldar J; Sawyer WH
    J Med Chem; 1978 Feb; 21(2):179-82. PubMed ID: 621712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Replacement of the disulfide bond in oxytocin by an amide group. Synthesis and some biological properties of (cyclo-(1-L-aspartic acid,6-L-alpha,beta-diaminopropionic acid))oxytocin.
    Smith CW; Walter R; Moore S; Makofske RC; Meienhofer J
    J Med Chem; 1978 Jan; 21(1):117-20. PubMed ID: 619141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological activities of [7-(azetidine-2-carboxylic acid)]-oxytocin and -lysine-vasopressin.
    Barber M; Jones JH; Stachulski AV; Bisset GW; Chowdrey HS; Hudson AL
    Int J Pept Protein Res; 1979; 14(3):247-61. PubMed ID: 521209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antidiuretic agonism and antagonism of some O-alkylated analogues of vasopressin containing 2-O-alkylated tyrosine.
    Melin P; Lundin S; Vilhardt H; Lindeberg G; Larsson LE; Pliska V
    Eur J Pharmacol; 1980 Oct; 67(2-3):173-7. PubMed ID: 7461030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potent antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),2-D- phenylalanine,4-valine]arginine-vasopressin at position 4.
    Manning M; Olma A; Klis WA; Seto J; Sawyer WH
    J Med Chem; 1983 Nov; 26(11):1607-13. PubMed ID: 6631916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of vasopressin-glycine and vasopressin-glycine-lysine-arginine on renal function in the rat.
    Lote CJ; McVicar AJ; Smyth DG
    J Endocrinol; 1986 Feb; 108(2):255-60. PubMed ID: 3950530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [1-(L-2-hydroxy-3-mercaptopropanoic acid)] analogues of arginine-vasopressin, [8-D-arginine]vasopressin, and [4-valine,8-D-arginine]vasopressin.
    Lowbridge J; Manning M; Haldar J; Sawyer W
    J Med Chem; 1977 Sep; 20(9):1173-6. PubMed ID: 926117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological activities of oxytocin and lysine vasopressin analogs containing glutamic acid gamma-hydrazide in position 4.
    Gazis D; Glass J; Schwartz IL; Stavropoulos G; Theodoropoulos D
    Int J Pept Protein Res; 1989 Nov; 34(5):353-7. PubMed ID: 2613436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solid-phase synthesis with attachment of peptide to resin through an amino acid side chain: (8-lysine)-vasopressin.
    Meienhofer J; Trzeciak A
    Proc Natl Acad Sci U S A; 1971 May; 68(5):1006-9. PubMed ID: 5280519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-Acetyl-[2-(O-methyl)tyrosine]arginine-vasopressin, an interesting antagonist of the vasopressor response to vasopressin.
    Jones DA; Sawyer WH
    J Med Chem; 1980 Jun; 23(6):696-8. PubMed ID: 7392038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 'Hormonogen' analogues of lysine vasopressin: rat pressor and antidiuretic activities.
    Kyncl J; Rezábek K; Kasafírek E; Pliska V; Rudinger J
    Eur J Pharmacol; 1974 Oct; 28(2):294-301. PubMed ID: 4422166
    [No Abstract]   [Full Text] [Related]  

  • 35. Design of potent antagonists of the vasopressor response to arginine-vasopressin.
    Bankowski K; Manning M; Haldar J; Sawyer WH
    J Med Chem; 1978 Sep; 21(9):850-3. PubMed ID: 722751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of [1-(L- and [1-(D-2-hydroxy-3-mercaptopropanoic acid)-8-lysine]-vasopressin.
    Wälti M; Hope DB
    J Chem Soc Perkin 1; 1975; (17):1691-4. PubMed ID: 1171891
    [No Abstract]   [Full Text] [Related]  

  • 37. Biofunctional evaluation of a hydrogen bond linking the ring and tail beta-turns of oxytocin.
    Roy J; Roy U; Gazis DC; Schwartz IL
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3309-13. PubMed ID: 291004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Solid phase synthesis and some hormonal activities of 1-deamino-4-L-valine-8-D-homolysine-and 1-deamino-4-L-valine-8-D-homoarginine-vasopressin.
    Lindeberg G; Karlsson SM; Melin P
    Int J Pept Protein Res; 1977; 10(3):240-4. PubMed ID: 914427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and some pharmacological properties of [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine]oxytocin (hydroxy [4-thr]oxytocin), a peptide with strikingly high oxytocic potency and of [1-(L-2-hydroxy-3-mercaptopropanoic acid)]oxytocin (hydroxy-oxytocin).
    Manning M; Lowbridge J; Sawyer WH; Haldar J
    J Med Chem; 1976 Mar; 19(3):376-80. PubMed ID: 943546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solid-phase synthesis and pressor potency of (1-deamino-9-ethylenediamine)-lysine-vasopressin.
    Glass JD; Du Vigneaud V
    J Med Chem; 1973 Feb; 16(2):160-1. PubMed ID: 4683112
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.